Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Harvard Apparatus Regenerative Technology, Inc.BSTG · Entity 7501 | Director | June 25, 2020 | June 29, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Harvard Apparatus Regenerative Technology, Inc.
Report date June 25, 2020 · Filed June 29, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.52 · Expires 2030-06-25 | Direct | 11,938 |
Reported balance
After 2020-06-25 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2020-06-25 · Grant · Acquired 11,938 · Balance 11,938 F1: This Stock Option represents the annual equity grant to the Reporting Person, as a non-employee director of the Issuer, and will vest in four equal installments on September 25, 2020, December 25, 2020, March 25, 2021, and June 25, 2021. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.52 · Expires 2030-06-25 | Direct | 21,517 |
Reported balance
After 2020-06-25 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2020-06-25 · Grant · Acquired 9,579 · Balance 21,517 F2: This Stock Option was granted in lieu of 2020 cash compensation otherwise payable to the Reporting Person, as a non-employee director of the Issuer, and will vest in four equal installments on the grant date, June 30, 2020, September 30, 2020 and December 31, 2020. |
Filing footnotes · ownership attribution and instrument terms
F1: This Stock Option represents the annual equity grant to the Reporting Person, as a non-employee director of the Issuer, and will vest in four equal installments on September 25, 2020, December 25, 2020, March 25, 2021, and June 25, 2021.
F2: This Stock Option was granted in lieu of 2020 cash compensation otherwise payable to the Reporting Person, as a non-employee director of the Issuer, and will vest in four equal installments on the grant date, June 30, 2020, September 30, 2020 and December 31, 2020.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 25, 2020 Filed Jun 29, 2020 23:52 UTC | Harvard Apparatus Regenerative Technology, Inc. BSTG · Entity 7501 | GrantStock Option (right to buy) · Derivative | 9,579 | $0.00 Strike: $2.52 | $0.00 |
DisclosureSEC source: 0001104659-20-078205 · tm2023734d3_4.xml · derivative · entry 2 Zhang Wei · CIK 0001742222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,517 Underlying: Common Stock, par value $0.01 per share · 9,579 shares Expires 2030-06-25 F2 · derivative.exercise_date: This Stock Option was granted in lieu of 2020 cash compensation otherwise payable to the Reporting Person, as a non-employee director of the Issuer, and will vest in four equal installments on the grant date, June 30, 2020, September 30, 2020 and December 31, 2020. Read SEC document |
| June 25, 2020 Filed Jun 29, 2020 23:52 UTC | Harvard Apparatus Regenerative Technology, Inc. BSTG · Entity 7501 | GrantStock Option (right to buy) · Derivative | 11,938 | $0.00 Strike: $2.52 | $0.00 |
DisclosureSEC source: 0001104659-20-078205 · tm2023734d3_4.xml · derivative · entry 1 Zhang Wei · CIK 0001742222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,938 Underlying: Common Stock, par value $0.01 per share · 11,938 shares Expires 2030-06-25 F1 · derivative.exercise_date: This Stock Option represents the annual equity grant to the Reporting Person, as a non-employee director of the Issuer, and will vest in four equal installments on September 25, 2020, December 25, 2020, March 25, 2021, and June 25, 2021. Read SEC document |
| June 03, 2019 Filed Jun 5, 2019 20:31 UTC | Harvard Apparatus Regenerative Technology, Inc. BSTG · Entity 7501 | GrantStock Option (right to buy) · Derivative | 5,128 | $0.00 Strike: $2.90 | $0.00 |
DisclosureSEC source: 0001144204-19-029893 · tv523166_form4.xml · derivative · entry 3 Zhang Wei · CIK 0001742222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,903 Underlying: Common Stock, par value $0.01 per share · 5,128 shares Expires 2029-06-03 F3 · security: This Stock Option was granted in lieu of 2018 cash compensation otherwise payable to the Reporting Person, as a non-employee director of the Issuer. Read SEC document |
| June 03, 2019 Filed Jun 5, 2019 20:31 UTC | Harvard Apparatus Regenerative Technology, Inc. BSTG · Entity 7501 | GrantStock Option (right to buy) · Derivative | 8,411 | $0.00 Strike: $2.90 | $0.00 |
DisclosureSEC source: 0001144204-19-029893 · tv523166_form4.xml · derivative · entry 2 Zhang Wei · CIK 0001742222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,775 Underlying: Common Stock, par value $0.01 per share · 8,411 shares Expires 2029-06-03 F2 · derivative.exercise_date: This Stock Option was granted in lieu of 2019 cash compensation otherwise payable to the Reporting Person, as a non-employee director of the Issuer, and will vest in four equal installments on the grant date, June 30, 2019, September 30, 2019, and December 31, 2019. Read SEC document |
| June 03, 2019 Filed Jun 5, 2019 20:31 UTC | Harvard Apparatus Regenerative Technology, Inc. BSTG · Entity 7501 | GrantStock Option (right to buy) · Derivative | 10,364 | $0.00 Strike: $2.90 | $0.00 |
DisclosureSEC source: 0001144204-19-029893 · tv523166_form4.xml · derivative · entry 1 Zhang Wei · CIK 0001742222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,364 Underlying: Common Stock, par value $0.01 per share · 10,364 shares Expires 2029-06-03 F1 · derivative.exercise_date: This Stock Option represents the annual equity grant to the Reporting Person, as a non-employee director of the Issuer, and will vest in four equal installments on September 3, 2019, December 3, 2019, March 3, 2020, and June 3, 2020. Read SEC document |
| November 13, 2018 Filed Nov 16, 2018 00:08 UTC | Harvard Apparatus Regenerative Technology, Inc. BSTG · Entity 7501 | GrantStock Option (right to buy) · Derivative | 10,897 | $0.00 Strike: $2.75 | $0.00 |
DisclosureSEC source: 0001144204-18-060326 · tv507435_form4.xml · derivative · entry 1 Zhang Wei · CIK 0001742222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,897 Underlying: Common Stock, par value $0.01 per share · 10,897 shares Expires 2028-11-13 F1 · derivative.exercise_date: The Stock Option shares will vest in four equal installments on February 13, 2019, May 13, 2019, August 13, 2019, and November 13, 2019. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.